Arcus Biosciences CFO Rekha Hemrajani receives $3.6M in 2019

Arcus Biosciences reports 2019 executive compensation

By ExecPay News

Published: April 21, 2020

Arcus Biosciences reported fiscal year 2019 executive compensation information on April 21, 2020.
In 2019, four executives at Arcus Biosciences received on average a compensation package of $2.7M, a 44% increase compared to previous year.
Average pay of disclosed executives at Arcus Biosciences
Rekha Hemrajani, Chief Financial Officer, received $3.6M in total. 84% of Hemrajani's compensation, or $3M, was in option awards. Hemrajani also received $200K in bonus, $234K in salary, as well as $142K in other compensation.
William Grossman, Chief Medical Officer, received a compensation package of $3.4M. 80% of the compensation package, or $2.7M, was in option awards.
Juan Carlos Jaen, President and Director, earned $2.1M in 2019, a 80% increase compared to previous year.
Terry Rosen, Chief Executive Officer, received $1.7M in 2019, which increases by 53% compared to 2018.

Related executives

Terry Rosen

Arcus Biosciences

Chief Executive Officer

Juan Jaen

Arcus Biosciences

President and Director

William Grossman

Arcus Biosciences

Chief Medical Officer

Rekha Hemrajani

Arcus Biosciences

Chief Financial Officer

You may also like

Source: SEC filing on April 21, 2020.